Sei Investments CO Vertex Pharmaceuticals Inc Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 214,469 shares of VRTX stock, worth $101 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

214,469

Previous 359,354 40.32%

Holding current value

$101 Million

Previous $146 Million 38.69%

% of portfolio

0.13%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $59.1 Million - $64.6 Million	-144,885 Reduced 40.32%	214,469 $89.7 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $13.7 Million - $16.4 Million	-39,864 Reduced 9.99%	359,354 $146 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $100,439 - $107,650	297 Added 0.07%	399,218 $139 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $44.2 Million - $49.4 Million	140,471 Added 54.35%	398,921 $140 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $52.1 Million - $59.5 Million	184,117 Added 247.69%	258,450 $81.4 Million

Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $10.6 Million - $12 Million	-37,235 Reduced 33.37%	74,333 $21.5 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $6.33 Million - $7.07 Million	23,129 Added 26.15%	111,568 $32.3 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $10.4 Million - $13 Million	44,349 Added 100.59%	88,439 $25.1 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $2.16 Million - $2.55 Million	9,761 Added 28.43%	44,090 $11.8 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $228,519 - $288,473	-1,291 Reduced 3.62%	34,329 $7.48 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $1.41 Million - $1.58 Million	-7,796 Reduced 17.96%	35,620 $6.46 Million
Q2 2021 Aug 06, 2021	SELL	$187.49 - $221.1 $512,972 - $604,929	-2,736 Reduced 5.93%	43,416 $8.74 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $6.2 Million - $7.22 Million	-29,939 Reduced 39.35%	46,152 $10.2 Million
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $9.07 Million - $12.1 Million	-43,830 Reduced 36.55%	76,091 $17.9 Million
Q3 2020 Dec 04, 2020	SELL	$255.65 - $303.1 $1.17 Million - $1.39 Million	-4,592 Reduced 3.69%	119,921 $32.7 Million
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $460,936 - $546,489	1,803 Added 1.47%	124,513 $33.9 Million
Q2 2020 Aug 17, 2020	SELL	$225.48 - $295.8 $2.52 Million - $3.31 Million	-11,198 Reduced 8.36%	122,710 $35.6 Million
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $507,780 - $666,141	-2,252 Reduced 1.65%	133,908 $32 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $2.39 Million - $2.97 Million	-11,973 Reduced 8.08%	136,160 $32.4 Million
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $1.03 Million - $1.39 Million	-6,193 Reduced 4.01%	148,133 $32.5 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $3.44 Million - $3.87 Million	20,690 Added 15.48%	154,326 $26.2 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $950,128 - $1.1 Million	-5,772 Reduced 4.14%	133,636 $24.5 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $753,485 - $896,009	4,602 Added 3.41%	139,408 $25.6 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $2.18 Million - $2.76 Million	14,351 Added 11.91%	134,806 $25.5 Million
Q3 2018 Nov 08, 2018	SELL	$167.73 - $192.74 $1.88 Million - $2.16 Million	-11,228 Reduced 8.53%	120,455 $23.2 Million
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $678,909 - $791,843	4,659 Added 3.67%	131,683 $22.4 Million
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $4.76 Million - $5.56 Million	-31,375 Reduced 19.81%	127,024 $20.7 Million
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $4.93 Million - $5.58 Million	35,880 Added 29.29%	158,399 $23.7 Million
Q3 2017 Nov 06, 2017	BUY	$148.13 - $162.24 $18.1 Million - $19.9 Million	122,519	122,519 $18.6 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Vertex Pharmaceuticals Inc Transaction History